Immunology · Sci Adv · 2021
The summary says the drug “reduces” white-cell self-destruction. The paper’s own tests show it rises.
Which way the drug moves the self-destruction of white cells
The paper says
White blood cells called neutrophils gather in inflamed tissue, then self-destruct; the paper says this helps the inflammation die down. Yet the summary at the top of the paper says its antibody drug, meant to end inflammation, “reduces” this self-destruction.
Its own data show
In a lab dish, after 10 hours, about 85% of drug-treated cells showed signs of self-destructing, versus about 45% with a do-nothing dummy. In inflamed mice, at 1 and 2 days, a larger share of white cells at the inflamed spot were dead with the drug. The paper’s main text says the same, five times.
Cells dying sounds bad, but here it is good: the paper calls appropriate self-destruction of these cells “fundamental” to ending inflammation, and ties delayed self-destruction to inflammatory bowel disease. Anyone reading only the summary gets this effect backwards. The data and main conclusions are not affected: in mice, inflammation still cleared faster with the drug.